At the moment I can only see a disappointing SP development. It's wishful thinking that FIL is accumulating. If broad market would give RAP very good chance to reach FDA approval SP should be already at least over 1 AUD. There are lots of doubts in the market sorry to say. I will put my rose glasses away for some days. There are no weak hands, no BOTs, no FIL who is accumulating etc. just only the market who is talking........IMO
Ann: ResApp Presentation at ASX Spotlight Investor Conference, page-53
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #